RWM
ELV icon

Revisor Wealth Management’s Elevance Health ELV Stock Holding History

Revisor Wealth Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.6M Buy
4,130
+120
+3% +$44.5K 0.38% 61
2026
Q1 		$1.17M Buy
4,010
+2,482
+162% +$816K 0.32% 77
2025
Q4 		$554K Buy
1,528
+709
+87% +$240K 0.15% 156
2025
Q3 		$293K Buy
819
+64
+8% +$19.9K 0.1% 213
2025
Q2 		$261K Buy
+755
New +$304K 0.09% 235

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Revisor Wealth Management's ELV Position: Q2 2026 in Review

Revisor Wealth Management increased its Elevance Health (ELV) stake by 3% in Q2 2026, buying an estimated $44.5K and bringing the position to 4,130 shares worth $1.6M. The position accounts for 0.38% of the portfolio, ranked #61.

Revisor Wealth Management first reported a position in ELV in Q2 2025 and has held it in 5 quarters since. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Revisor Wealth Management held 4,130 shares of Elevance Health worth $1.6M as of Q2 2026.
  • Revisor Wealth Management bought 120 Elevance Health shares in Q2 2026, an estimated $44.5K.
  • Elevance Health made up 0.38% of Revisor Wealth Management's portfolio in Q2 2026, its #61 holding.
  • Revisor Wealth Management first reported a position in Elevance Health in Q2 2025 and has held it in 5 quarters since.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Revisor Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.